Literature DB >> 28343835

Cancer Screening and Early Detection in the 21st Century.

Jennifer T Loud, Jeanne Murphy.   

Abstract

OBJECTIVE: To review the trends in and principles of cancer screening and early detection. DATA SOURCES: Journal articles, United States Preventive Services Task Force (USPSTF) publications, professional organization position statements, and evidence-based summaries.
CONCLUSION: Cancer screening has contributed to decreasing the morbidity and mortality of cancer. Efforts to improve the selection of candidates for cancer screening, to understand the biological basis of carcinogenesis, and the development of new technologies for cancer screening will allow for improvements in cancer screening over time. IMPLICATIONS FOR NURSING PRACTICE: Nurses are well-positioned to lead the implementation of cancer screening recommendations in the 21st century through their practice, research, educational efforts, and advocacy. Published by Elsevier Inc.

Entities:  

Keywords:  cancer screening; decision-making; early detection; screening recommendations; sensitivity; specificity

Mesh:

Year:  2017        PMID: 28343835      PMCID: PMC5467686          DOI: 10.1016/j.soncn.2017.02.002

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  31 in total

Review 1.  Practice Bulletin No. 168: Cervical Cancer Screening and Prevention.

Authors: 
Journal:  Obstet Gynecol       Date:  2016-10       Impact factor: 7.661

2.  Committee Opinion No. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer.

Authors: 
Journal:  Obstet Gynecol       Date:  2011-03       Impact factor: 7.661

3.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Authors:  F P Li; J F Fraumeni
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

4.  The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: Performance and complications.

Authors:  Maryam Doroudi; Barnett S Kramer; Paul F Pinsky
Journal:  J Med Screen       Date:  2016-11-30       Impact factor: 2.136

5.  The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections.

Authors:  Tim Byers; Richard C Wender; Ahmedin Jemal; Arnold M Baskies; Elizabeth E Ward; Otis W Brawley
Journal:  CA Cancer J Clin       Date:  2016-05-13       Impact factor: 508.702

Review 6.  Prognostic indices for older adults: a systematic review.

Authors:  Lindsey C Yourman; Sei J Lee; Mara A Schonberg; Eric W Widera; Alexander K Smith
Journal:  JAMA       Date:  2012-01-11       Impact factor: 56.272

7.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

Authors:  M H Gail; L A Brinton; D P Byar; D K Corle; S B Green; C Schairer; J J Mulvihill
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

Review 8.  Biomarkers for screening, diagnosis, and monitoring of ovarian cancer.

Authors:  Eiji Kobayashi; Yutaka Ueda; Shinya Matsuzaki; Takuhei Yokoyama; Toshihiro Kimura; Kiyoshi Yoshino; Masami Fujita; Tadashi Kimura; Takayuki Enomoto
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-09-07       Impact factor: 4.254

9.  Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer: A Meta-analysis.

Authors:  Farshid Dayyani; Steffen Uhlig; Bertrand Colson; Kirsten Simon; Vinzent Rolny; David Morgenstern; Matthew Schlumbrecht
Journal:  Int J Gynecol Cancer       Date:  2016-11       Impact factor: 3.437

10.  Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

Authors:  Ian J Jacobs; Usha Menon; Andy Ryan; Aleksandra Gentry-Maharaj; Matthew Burnell; Jatinderpal K Kalsi; Nazar N Amso; Sophia Apostolidou; Elizabeth Benjamin; Derek Cruickshank; Danielle N Crump; Susan K Davies; Anne Dawnay; Stephen Dobbs; Gwendolen Fletcher; Jeremy Ford; Keith Godfrey; Richard Gunu; Mariam Habib; Rachel Hallett; Jonathan Herod; Howard Jenkins; Chloe Karpinskyj; Simon Leeson; Sara J Lewis; William R Liston; Alberto Lopes; Tim Mould; John Murdoch; David Oram; Dustin J Rabideau; Karina Reynolds; Ian Scott; Mourad W Seif; Aarti Sharma; Naveena Singh; Julie Taylor; Fiona Warburton; Martin Widschwendter; Karin Williamson; Robert Woolas; Lesley Fallowfield; Alistair J McGuire; Stuart Campbell; Mahesh Parmar; Steven J Skates
Journal:  Lancet       Date:  2015-12-17       Impact factor: 79.321

View more
  31 in total

1.  Distinguishing Rectal Cancer from Colon Cancer Based on the Support Vector Machine Method and RNA-sequencing Data.

Authors:  Yan Zhang; Yuan Wu; Zi-Ying Gong; Hai-Dan Ye; Xiao-Kai Zhao; Jie-Yi Li; Xiao-Mei Zhang; Sheng Li; Wei Zhu; Mei Wang; Ge-Yu Liang; Yun Liu; Xin Guan; Dao-Yun Zhang; Bo Shen
Journal:  Curr Med Sci       Date:  2021-04-20

Review 2.  Cancer Screening Considerations and Cancer Screening Uptake for Lesbian, Gay, Bisexual, and Transgender Persons.

Authors:  Marc Ceres; Gwendolyn P Quinn; Matthew Loscalzo; David Rice
Journal:  Semin Oncol Nurs       Date:  2018-01-08       Impact factor: 2.315

3.  Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites.

Authors:  Naomi D Atkin; Heather M Raimer; Zhenjia Wang; Chongzhi Zang; Yuh-Hwa Wang
Journal:  Genes Chromosomes Cancer       Date:  2021-08-26       Impact factor: 5.006

4.  Interest in genetic testing and risk-reducing behavioral changes: results from a community health assessment in New York City.

Authors:  Sarah M Lima; Meaghan Nazareth; Karen M Schmitt; Andria Reyes; Elaine Fleck; Gary K Schwartz; Mary Beth Terry; Grace C Hillyer
Journal:  J Community Genet       Date:  2022-10-13

Review 5.  Label-Free Sensing with Metal Nanostructure-Based Surface-Enhanced Raman Spectroscopy for Cancer Diagnosis.

Authors:  Marios Constantinou; Katerina Hadjigeorgiou; Sara Abalde-Cela; Chrysafis Andreou
Journal:  ACS Appl Nano Mater       Date:  2022-08-22

Review 6.  Metastasis prevention: targeting causes and roots.

Authors:  A A Schegoleva; A A Khozyainova; T S Gerashchenko; L D Zhuikova; Evgeny V Denisov
Journal:  Clin Exp Metastasis       Date:  2022-03-26       Impact factor: 4.510

Review 7.  What is the significance of monoclonal gammopathy of undetermined significance?

Authors:  Catherine Atkin; Alex Richter; Elizabeth Sapey
Journal:  Clin Med (Lond)       Date:  2018-10       Impact factor: 2.659

Review 8.  Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey.

Authors:  Antonio Jesús Banegas-Luna; Jorge Peña-García; Adrian Iftene; Fiorella Guadagni; Patrizia Ferroni; Noemi Scarpato; Fabio Massimo Zanzotto; Andrés Bueno-Crespo; Horacio Pérez-Sánchez
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

Review 9.  Targeting Akt-associated microRNAs for cancer therapeutics.

Authors:  Mir S Adil; Daulat Khulood; Payaningal R Somanath
Journal:  Biochem Pharmacol       Date:  2020-12-24       Impact factor: 6.100

Review 10.  Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.

Authors:  Saiful Islam; Shudong Wang; Nikola Bowden; Jennifer Martin; Richard Head
Journal:  Br J Clin Pharmacol       Date:  2021-07-09       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.